scholarly journals Identification of a key regulatory element for the basal activity of the human insulin-like growth factor II gene promoter P3

1997 ◽  
Vol 327 (3) ◽  
pp. 689-697 ◽  
Author(s):  
E. G. Luc RIETVELD ◽  
P. Elly HOLTHUIZEN ◽  
S. John SUSSENBACH

Transcription of the human insulin-like growth factor II (IGF-II) gene is under the control of four promoters (P1-P4) that are differentially active during growth and development. Promoter 3 (P3) is the most active promoter during fetal development as well as in most adult tissues. P3 is also the most active promoter in tumour tissues and cell lines expressing IGF-II. Transient transfections of HeLa and Hep3B cells with truncated promoter constructs revealed that the region between -289 and -183 relative to the transcription start site supports basal promoter activity in both cell lines. Footprint experiments showed that the region between positions -192 and -172 (P3-4) is the only element bound by nuclear proteins. P3-4 is bound by five proteins, of which three proteins (proteins 3, 4 and 5) bind specifically and are expressed at the same levels in HeLa and Hep3B cells. Electrophoretic mobility shift assays and differential footprint experiments revealed the presence of two protein-binding regions within the P3-4 element. Proteins 4 and 5 bind box A (-193 to -188), whereas box B (-183 to -172) is bound by protein 3. From transcription experiments in vitro it can be concluded that Box A is essential for P3 activity. Box A is part of a region 11 dG residues long and is protected by proteins 4 and 5 that bind a contiguous set of six dG residues. DNA-binding of proteins 4 and 5 to box A requires the presence of Zn2+ ions. Thus structural and functional analysis reveals that the P3-4 element is a key regulatory element of P3 that contains two separate binding sites for proteins essential for the basal activity of IGF-II P3.

1996 ◽  
Vol 318 (1) ◽  
pp. 195-201 ◽  
Author(s):  
Wiep SCHEPER ◽  
Elly HOLTHUIZEN ◽  
John S P. SUSSENBACH

Insulin-like growth factor II (IGF-II) is synthesized in many tissues, but the main site of production is the liver. In this paper we show that IGF-II mRNA levels are dependent on the growth conditions of the cells. In Hep3B cells, serum deprivation leads to a marked increase in IGF-II mRNA levels. Serum stimulation of starved Hep3B cells induces a decrease in the amount of IGF-II mRNA, which is not caused by a change in promoter activity. IGF-II mRNAs are subject to endonucleolytic cleavage, a process that requires two widely separated elements in the 3´ untranslated region of the mRNA. Specific regions of these elements can form a stable stem structure which is involved in the formation of RNA–protein complexes. By employing electrophoretic mobility shift assays, two complexes have been identified in cytoplasmic extracts of Hep3B cells. The formation of these complexes is related to the growth conditions of the cells and is correlated with the regulation of IGF-II mRNA levels. Our data suggest that, depending on whether serum is present or absent, a transition from one complex to the other occurs. A decrease in the IGF-II mRNA level is also observed when IGF-I or IGF-II is added to serum-deprived Hep3B cells, possibly providing a feedback mechanism for IGF-II production. The serum-induced degradation of IGF-II mRNAs does not require de novo protein synthesis, and is abolished by rapamycin, an inhibitor of p70 S6 kinase.


1991 ◽  
Vol 81 (1-3) ◽  
pp. 81-94 ◽  
Author(s):  
M.A. van Dijk ◽  
F.M.A. van Schaik ◽  
H.J. Bootsma ◽  
P. Holthuizen ◽  
J.S. Sussenbach

FEBS Letters ◽  
1996 ◽  
Vol 394 (1) ◽  
pp. 25-30 ◽  
Author(s):  
Richard J.T. Rodenburg ◽  
Jorrit-Jan T. Krijger ◽  
P.Elly Holthuizen ◽  
John S. Sussenbach

1999 ◽  
Vol 52 (4) ◽  
pp. 178-185 ◽  
Author(s):  
Martin W. Elmlinger ◽  
Uta Rauschnabel ◽  
Ewa Koscielniak ◽  
Karin Weber ◽  
Michael B. Ranke

Sign in / Sign up

Export Citation Format

Share Document